Patents by Inventor Xiuwei YANG

Xiuwei YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220323525
    Abstract: The present invention discloses Fuke Qianjin Tablets and a quality control method therefor. The Fuke Qianjin Tablets are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Tablets contains not less than 0.008 mg of the genistin, not less than 0.7 mg of the Z-ligustilide, and the total amount of the andrographolide and the dehydroandrographolide is not less than 1.1 mg.
    Type: Application
    Filed: January 14, 2020
    Publication date: October 13, 2022
    Applicant: QIANJIN PHARMACEUTICAL CO., LTD.
    Inventors: Duanyu JIANG, Peng ZHANG, Yun GONG, Fujun LI, Yingshuai ZHANG, Lu BAI, Wei ZHAO, Kanghua WANG, Xiuwei YANG
  • Publication number: 20220203824
    Abstract: The present disclosure provides a vehicle component comprising: at least two movable blades; and an actuator receiving an activation signal and driving at least one of the blades to move between a first position and a second position to exhibit a particular action. The present disclosure also provides a control method of the vehicle component, wherein the component comprises at least two movable blades. The control method comprises: driving the blade of the vehicle component to move between a first position and a second position based on an activation signal to exhibit a particular action. According to the present disclosure, the component and the control method thereof can meet people's demand for producing attractive visual effects with customized actions or patterns, and bring better vehicle use experience.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 30, 2022
    Inventors: Andrew Liu, Eric Pan, Xiuwei Yang, Silver Zhou, Roy Zhang
  • Publication number: 20220143125
    Abstract: The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.
    Type: Application
    Filed: January 14, 2020
    Publication date: May 12, 2022
    Applicant: QIANJIN PHARMACEUTICAL CO., LTD.
    Inventors: Shun JIAN, Yun GONG, Peng ZHANG, Fujun LI, Yonggen LING, Juanjuan HE, Kanghua WANG, Xiuwei YANG